These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3360003)

  • 21. Risk factors for visceral leishmaniasis in a new epidemic site in Amhara Region, Ethiopia.
    Bashaye S; Nombela N; Argaw D; Mulugeta A; Herrero M; Nieto J; Chicharro C; Cañavate C; Aparicio P; Vélez ID; Alvar J; Bern C
    Am J Trop Med Hyg; 2009 Jul; 81(1):34-9. PubMed ID: 19556563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Visceral and cutaneous leishmaniases in the north. Retrospective study of cases diagnosed in the Rabta Hospital of Tunis].
    Belhadj S; Djaiet-Baraket Z; Jemli B; Benosman A; Chaker E
    Bull Soc Pathol Exot; 1996; 89(4):269-73. PubMed ID: 9053047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haematological findings in relation to clinical findings of visceral Leishmaniasis in Hazara Division.
    Rai ME; Muhammad Z; Sarwar J; Qureshi AM
    J Ayub Med Coll Abbottabad; 2008; 20(3):40-3. PubMed ID: 19610513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Visceral and cutaneous leishmaniasis in Huesca. Epidemiologic aspects].
    Vera F; Viñuales S; Tajada N; Gallardo C; Díaz N; Oliván MJ; Lacasa A; Gonzalvo N
    An Esp Pediatr; 1985 Dec; 23(8):551-4. PubMed ID: 4096449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outbreak of visceral leishmaniasis in the western bank of the White Nile--Sudan, report and clinical study.
    Ahmed MA; Suleman SM; Kordofani AA; Mustafa MD
    East Afr Med J; 1988 Dec; 65(12):824-8. PubMed ID: 3234274
    [No Abstract]   [Full Text] [Related]  

  • 26. Visceral leishmaniasis in Honduras. Report of three proven cases and a suspected case.
    Nuernberger SP; Ramos CV; Custodio R
    Am J Trop Med Hyg; 1975 Nov; 24(6 Pt 1):917-20. PubMed ID: 1200256
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypocholesterolemia and increased triglyceride in pediatric visceral leishmaniasis.
    Lal CS; Kumar A; Kumar S; Pandey K; Kumar N; Bimal S; Sinha PK; Das P
    Clin Chim Acta; 2007 Jul; 382(1-2):151-3. PubMed ID: 17509550
    [No Abstract]   [Full Text] [Related]  

  • 28. [First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France].
    Minodier P; Robert S; Noël G; Blanc P; Retornaz K; Garnier JM
    Arch Pediatr; 2005 Jul; 12(7):1102-8. PubMed ID: 15964525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The distribution of visceral leishmaniasis in Ethiopia.
    Ayele T; Ali A
    Am J Trop Med Hyg; 1984 Jul; 33(4):548-52. PubMed ID: 6476199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroepidemiological study of visceral leishmaniasis among humans and animal reservoirs in Bushehr province, Islamic Republic of Iran.
    Mohebali M; Hamzavi Y; Edrissian GH; Forouzani A
    East Mediterr Health J; 2001 Nov; 7(6):912-7. PubMed ID: 15332732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kala-azar in Ethiopia: Epidemiological studies in a highland valley.
    Ashford RW; Hutchinson MP; Bray RS
    Ethiop Med J; 1973 Oct; 11(4):259-64. PubMed ID: 4803210
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies in the epidemiology of East African leishmaniasis. 3. Immunity as a determinant of geographical distribution.
    Southgate BA; Oriedo BV
    J Trop Med Hyg; 1967 Jan; 70(1):1-4. PubMed ID: 6016816
    [No Abstract]   [Full Text] [Related]  

  • 33. The leishmaniases. Report of a WHO Expert Committee.
    World Health Organ Tech Rep Ser; 1984; 701():1-140. PubMed ID: 6428052
    [No Abstract]   [Full Text] [Related]  

  • 34. Contribution study of visceral leishmaniasis in Syria.
    Al-Nahhas S; Shaaban M; Hammoud L
    Saudi Med J; 2005 Mar; 26(3):490-2. PubMed ID: 15806230
    [No Abstract]   [Full Text] [Related]  

  • 35. [Kala-azar in a hospital for infectious diseases. Review of 104 cases].
    Mariscal Sistiaga F; Domínguez Moreno B; Lenguas Portero F; Martínez Forde JM; Galván Guijo B
    Rev Clin Esp; 1980 Oct; 159(1):47-50. PubMed ID: 7465883
    [No Abstract]   [Full Text] [Related]  

  • 36. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.
    Sundar S; More DK; Singh MK; Singh VP; Sharma S; Makharia A; Kumar PC; Murray HW
    Clin Infect Dis; 2000 Oct; 31(4):1104-7. PubMed ID: 11049798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human and canine leishmaniasis in asymptomatic and symptomatic population in Northwestern Greece.
    Papadopoulou C; Kostoula A; Dimitriou D; Panagiou A; Bobojianni C; Antoniades G
    J Infect; 2005 Jan; 50(1):53-60. PubMed ID: 15603841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Visceral leishmaniasis in western Galilee. Epidemiological review of the years 1960-9].
    Freundlich E; May M
    Harefuah; 1972 Sep; 83(6):223-5. PubMed ID: 4650392
    [No Abstract]   [Full Text] [Related]  

  • 39. [Kala-azar in Turkey. Its relationship to canine leishmaniasis].
    Yasarol S
    Ann Parasitol Hum Comp; 1965; 40(6):643-50. PubMed ID: 5893481
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ecology of leishmaniasis in the south of France. 14. Leishmaniasis of man in the Cévennes: a clinical and biological analysis of visceral and mucosal forms (author's transl)].
    Lanotte G; Rioux JA; Pratlong F
    Ann Parasitol Hum Comp; 1980; 55(6):635-43. PubMed ID: 7469304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.